At an FDA advisory panel Listening to held in September to review liraglutide's feasible obesity indication, David W Cooke, MD, affiliate professor of pediatrics and scientific director of pediatric endocrinology at Johns Hopkins University, Baltimore, Maryland, reported, "I believed the data quite Obviously supported efficacy in terms of weight lo